The Basal Ganglia is a group of structures located deep within the brain, which is made up of neurons that send electrical impulses to other parts of the brain to coordinate movement. These structures are important for controlling voluntary movements, such as walking, and maintaining balance and posture when standing or sitting. Basal Ganglia diseases involve damage to these structures, leading to impairments in movement, balance, and posture. The most common Basal Ganglia diseases are Parkinson’s disease, Huntington’s disease, and tardive dyskinesia. Parkinson’s disease is characterized by a lack of dopamine-containing neurons in the Substantia Nigra region of the Basal Ganglia, which causes problems with motor coordination, balance, and posture. Typical symptoms include tremor, stiffness, and a slowing of movement. Huntington’s disease is another disorder of the Basal Ganglia, caused by genetic defects that cause progressive deterioration of the brain, leading to the death of neurons and the death of the person from complete brain disintegration. Symptoms of Huntington’s disease include jerky movements, loss of coordination, and mental deterioration. Tardive dyskinesia is often caused by long-term use of antipsychotic medications and is characterized by writhing and involuntary movements. More recently, research has also suggested that other Basal Ganglia diseases, such as Tourette’s syndrome, Gilles de la Tourette Syndrome, developmental delay, and autism, may be caused by dysfunction in the Basal Ganglia. In each of these disorders, impairments in motor coordination and posture are common, as well as issues with language and communication. Treatment of Basal Ganglia diseases can vary greatly, depending on the specific disorder. For example, treatment of Parkinson’s disease often involves medications that increase dopamine levels in the brain, while Huntington’s disease is often treated with a combination of medications, physical therapy, and lifestyle modifications. Additionally, therapies such as deep brain stimulation and transcranial magnetic stimulation have also been used to help improve the symptoms of Basal Ganglia diseases. In summary, Basal Ganglia diseases involve damage to the structures in the brain responsible for controlling movement, balance, and posture.
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Modeling early neurologic trajectories after elevated leg positioning (ELP): A secondary analysis of the LEG-UP randomized feasibility study
Kayode Ahmed, The University of Texas MD Anderson Cancer Center, United States
Title : Neuro-exergaming for non-verbal autism spectrum: A case study of neuropsychological function after 15 sessions of pedal-n-play iPACES
Cay Anderson Hanley, iPACES, United States
Title : Prescribing joy: The importance of integrating memory cafes into dementia care
Saul Beaumont, Massachusetts Advisory Council on Alzheimer's Disease and All Other Dementias, United States